PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
CRISPR screening identifies novel PARP inhibitor classification based on distinct base excision repair pathway dependencies | bioRxiv
Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance | Nature Communications
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
Unsprung traps keep PARP inhibitors effective | Nature Cell Biology
The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks - ScienceDirect
Serine-linked PARP1 auto-modification controls PARP inhibitor response | Nature Communications
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Advances and perspectives of PARP inhibitors | Experimental Hematology & Oncology | Full Text
Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance: Trends in Molecular Medicine
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
PARP1, but not PARP2, deletion desensitizes cells to clinical PARP... | Download Scientific Diagram
When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials - European Urology Oncology
Cancers | Free Full-Text | PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword | HTML
Inhibitors of PARP: Number crunching and structure gazing | PNAS
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/4-Figure1-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
Clinical PARP inhibitors (PARPis) and determinants of response and... | Download Scientific Diagram
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in Cell Biology
Frontiers | PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance | Cell and Developmental Biology
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs | Nature Communications
Frontiers | Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy | Molecular Biosciences
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
